Literature DB >> 22527136

Excess weight and associated risk factors in patients with systemic lupus erythematosus.

Fabiana de Miranda Moura dos Santos1, Mariane Curado Borges, Rosa Weiss Telles, Maria Isabel T D Correia, Cristina Costa Duarte Lanna.   

Abstract

The objective of this study is to determine the socio-demographic, clinical and laboratory characteristics of outpatients with SLE who present with excess weight as well as to assess the immunosuppressive therapy used. One hundred and seventy women with SLE were evaluated consecutively in a transversal study. The relationship between excess weight and the patients' characteristics was evaluated using univariate and multivariate Poisson regression analysis. Of the 170 patients evaluated, 109 presented with excess weight, two were malnourished and 59 were classified as eutrophic. Age and disease duration of those with excess weight were 42.4 ± 8.7 and 10.4 ± 6.2 years, respectively. Risk factors associated with excess weight were the following: age ≥40 years, <8 years of education, lack of occupation, damage index ≥1, systemic high blood pressure, diabetes mellitus and triglycerides ≥150 mg/dL levels. The use of antimalarial therapy and steroids was associated with a lower frequency of excess weight. Age ≥40 years and the non-usage of methotrexate were the variables independently associated with excess weight in the multivariate analysis. Patients with SLE who have excess weight present distinct clinical-laboratory findings, socio-demographic characteristics and treatment options when compared to normal weight patients. Prospective studies should assess whether these characteristics will interfere with the outcome or prognosis of lupus.

Entities:  

Mesh:

Year:  2012        PMID: 22527136     DOI: 10.1007/s00296-012-2402-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  36 in total

1.  Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group.

Authors:  G S Alarcón; G McGwin; H M Bastian; J Roseman; J Lisse; B J Fessler; A W Friedman; J D Reveille
Journal:  Arthritis Rheum       Date:  2001-04

2.  [V Brazilian Guidelines in Arterial Hypertension. ].

Authors: 
Journal:  Arq Bras Cardiol       Date:  2007-09       Impact factor: 2.000

3.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

4.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

5.  Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity.

Authors:  Elvira Haas; Indranil Bhattacharya; Eugen Brailoiu; Marlen Damjanović; G Cristina Brailoiu; Xin Gao; Laurence Mueller-Guerre; Nicole A Marjon; André Gut; Roberta Minotti; Matthias R Meyer; Kerstin Amann; Emerita Ammann; Ana Perez-Dominguez; Michele Genoni; Deborah J Clegg; Nae J Dun; Thomas C Resta; Eric R Prossnitz; Matthias Barton
Journal:  Circ Res       Date:  2009-01-29       Impact factor: 17.367

6.  Body mass index and the risk of development of end-stage renal disease in a screened cohort.

Authors:  Kunitoshi Iseki; Yoshiharu Ikemiya; Kozen Kinjo; Taku Inoue; Chiho Iseki; Shuichi Takishita
Journal:  Kidney Int       Date:  2004-05       Impact factor: 10.612

Review 7.  Methotrexate in systemic lupus erythematosus.

Authors:  J M Wong; J M Esdaile
Journal:  Lupus       Date:  2005       Impact factor: 2.911

8.  Metabolic syndrome in Argentinean patients with systemic lupus erythematosus.

Authors:  V Bellomio; A Spindler; E Lucero; A Berman; R Sueldo; H Berman; M Santana; M J Molina; V Góngora; G Cassano; S Paira; V Saurit; S Retamozo; G Retamozo; A Alvarellos; F Caerio; P Alba; M Gotero; E J Velozo; F Ceballos; E Soriano; L Catoggio; M A García; A Eimon; S Agüero
Journal:  Lupus       Date:  2009-10       Impact factor: 2.911

Review 9.  The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.

Authors:  D Gladman; E Ginzler; C Goldsmith; P Fortin; M Liang; M Urowitz; P Bacon; S Bombardieri; J Hanly; E Hay; D Isenberg; J Jones; K Kalunian; P Maddison; O Nived; M Petri; M Richter; J Sanchez-Guerrero; M Snaith; G Sturfelt; D Symmons; A Zoma
Journal:  Arthritis Rheum       Date:  1996-03

10.  Risk factors for coronary artery disease in patients with systemic lupus erythematosus.

Authors:  M Petri; S Perez-Gutthann; D Spence; M C Hochberg
Journal:  Am J Med       Date:  1992-11       Impact factor: 4.965

View more
  9 in total

1.  A systematic review of the association of obesity with the outcomes of inflammatory rheumatic diseases.

Authors:  Yi Xuan Lee; Yu Heng Kwan; Ka Keat Lim; Chuen Seng Tan; Nai Lee Lui; Jie Kie Phang; Eng Hui Chew; Truls Ostbye; Julian Thumboo; Warren Fong
Journal:  Singapore Med J       Date:  2019-06       Impact factor: 1.858

2.  Homocysteine, folate, hs-C-reactive protein, tumor necrosis factor alpha and inflammatory proteins: are these biomarkers related to nutritional status and cardiovascular risk in childhood-onset systemic lupus erythematosus?

Authors:  Roberta Garcia Salomão; Luciana Martins de Carvalho; Clarice Izumi; Érika Silva Czernisz; José César Rosa; Sonir Roberto Rauber Antonini; Ana Carolina Bueno; Maria Olímpia Ribeiro do Vale Almada; Carolina de Almeida Coelho-Landell; Alceu Afonso Jordão; Virgínia Paes Leme Ferriani; Jacqueline Pontes Monteiro
Journal:  Pediatr Rheumatol Online J       Date:  2018-01-09       Impact factor: 3.054

3.  Relationship of Excess Weight with Clinical Activity and Dietary Intake Deficiencies in Systemic Lupus Erythematosus Patients.

Authors:  Mónica R Meza-Meza; Barbara Vizmanos-Lamotte; José Francisco Muñoz-Valle; Isela Parra-Rojas; Marta Garaulet; Bertha Campos-López; Margarita Montoya-Buelna; Sergio Cerpa-Cruz; Erika Martínez-López; Edith Oregon-Romero; Ulises De la Cruz-Mosso
Journal:  Nutrients       Date:  2019-11-06       Impact factor: 5.717

4.  CRP Serum Levels Are Associated with High Cardiometabolic Risk and Clinical Disease Activity in Systemic Lupus Erythematosus Patients.

Authors:  Karen Pesqueda-Cendejas; Isela Parra-Rojas; Paulina E Mora-García; Margarita Montoya-Buelna; Adolfo I Ruiz-Ballesteros; Mónica R Meza-Meza; Bertha Campos-López; Melissa Rivera-Escoto; Barbara Vizmanos-Lamotte; Sergio Cerpa-Cruz; Ulises de la Cruz-Mosso
Journal:  J Clin Med       Date:  2022-03-26       Impact factor: 4.241

5.  Lifestyle Interventions and Weight Management in Systemic Lupus Erythematosus Patients: A Systematic Literature Review and Metanalysis.

Authors:  Karla F Goessler; Bruno Gualano; Carla B Nonino; Eloisa Bonfá; Carolina Ferreira Nicoletti
Journal:  J Lifestyle Med       Date:  2022-01-31

6.  Serum Immunoglobulin M Concentration Varies with Triglyceride Levels in an Adult Population: Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIHealth) Cohort Study.

Authors:  Hongbin Shi; Xiaoyan Guo; Qing Zhang; Hongmei Wu; Huanmin Du; Li Liu; Chongjin Wang; Yang Xia; Xing Liu; Chunlei Li; Shaomei Sun; Xing Wang; Ming Zhou; Qiyu Jia; Honglin Zhao; Kun Song; Dianjun Wei; Kaijun Niu
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

7.  Cardiovascular disease in latin american patients with systemic lupus erythematosus: a cross-sectional study and a systematic review.

Authors:  Jenny Amaya-Amaya; Juan Camilo Sarmiento-Monroy; Julián Caro-Moreno; Nicolás Molano-González; Rubén D Mantilla; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  Autoimmune Dis       Date:  2013-11-03

Review 8.  Cardiovascular involvement in autoimmune diseases.

Authors:  Jenny Amaya-Amaya; Laura Montoya-Sánchez; Adriana Rojas-Villarraga
Journal:  Biomed Res Int       Date:  2014-07-22       Impact factor: 3.411

9.  Immunomodulatory Effects of Diet and Nutrients in Systemic Lupus Erythematosus (SLE): A Systematic Review.

Authors:  Md Asiful Islam; Shahad Saif Khandker; Przemysław J Kotyla; Rosline Hassan
Journal:  Front Immunol       Date:  2020-07-22       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.